GastroHealth Probiotic Dairy Free

Australia - English - Department of Health (Therapeutic Goods Administration)

Buy It Now

Active ingredient:
Bifidobacterium lactis,inulin,Lactobacillus acidophilus,Lactobacillus plantarum
Available from:
Cat Media Pty Ltd
Authorization status:
Authorization number:

Read the complete document

Public Summary

Summary for ARTG Entry:


GastroHealth Probiotic Dairy Free

ARTG entry for

Medicine Listed


Cat Media Pty Ltd

Postal Address

PO Box 384, MONA VALE, NSW, 1660


ARTG Start Date


Product Category




Approval Area

Listed Medicines


Colouring agents used in listed medicine for ingestion, other than those listed for export only under section 25 of the Act, shall be only those included in the list

of 'Colourings permitted in medicines for oral use'.

The sponsor shall keep records relating to this listed medicine as are necessary to: (a) Expedite recall if necessary of any batch of the listed medicine, (b)

Identify the manufacturer(s) of each batch of the listed medicine. Where any part of or step in manufacture in Australia of the listed medicine is sub-contracted

to a third party who is not the sponsor, copies of relevant Good Manufacturing Practice agreements relation to such manufacture shall be kept.

The sponsor shall retain records of the distribution of the listed medicine for a period of five years and shall provide the records or copies of the records to the

Complementary Medicines Branch, Therapeutic Goods Administration, upon request.

Where a listed medicine is distributed overseas as well as in Australia, product recall or any other regulatory action taken in relation to the medicine outside

Australia which has or may have relevance to the quality, safety or efficacy of the goods distributed in Australia, must be notified to the National Manager

Therapeutic Goods Administration, immediately the action or information is known to the sponsor.


1 . GastroHealth Probiotic Dairy Free

Product Type

Single Medicine Product

Effective Date


Permitted Indications

Maintain/support general health and wellbeing

Maintain/support bowel regularity

Maintain/support healthy bowel/colon function

Decrease/reduce/relieve excess intestinal gas

Maintain/support intestinal health

Maintain/support healthy digestion

Maintain/support digestive system health

Maintain/support good/beneficial/friendly bacteria adherence to intestinal mucosa

Maintain/support intestinal good/beneficial/friendly flora

Maintain/support gastrointestinal system health

Maintain/support gastrointestinal mucosal membrane health

Decrease/reduce/relieve abdominal bloating/distention

Relieve digestive discomfort

Maintain/support immune system health

Maintain/support healthy immune system function

Maintain/support healthy gastrointestinal immune function

Indication Requirements

Label statement: If symptoms persist, talk to your health professional.

Label statement for stimulant laxatives: Prolonged use may cause serious bowel problems.

Label statement: Do not use when abdominal pain, nausea or vomiting are present or if you develop diarrhoea. If you are pregnant or breastfeeding - seek

the advice of a healthcare professional before taking this product (or words to that effect).

Product presentation must not refer to or imply weight loss.

Product presentation must not imply or refer to serious immunological diseases.

Product presentation must not imply or refer to gastro oesophageal reflux disease.

Label statement: Drink plenty of water (or words to that effect).

Standard Indications

Public Summary

Page 1 of

Produced at 11.01.2021 at 11:53:04 AEDT

This is not an ARTG Certificate document.

The onus is on the reader to verify the current accuracy of the information on the document subsequent to the date shown.

Visit for contact information

No Standard Indications included on Record

Specific Indications

No Specific Indications included on Record


No Warnings included on Record

Additional Product information

Pack Size/Poison information

Pack Size

Poison Schedule


1 . Formulation 1

Dosage Form

Capsule, hard

Route of Administration


Visual Identification

Active Ingredients

Bifidobacterium lactis

2.5 billion CFU


40 mg

Lactobacillus acidophilus

12.5 billion CFU

Lactobacillus plantarum

5 billion CFU

Other Ingredients (Excipients)


magnesium stearate

microcrystalline cellulose

silicon dioxide

titanium dioxide

© Commonwealth of Australia. This work is copyright. You are not permitted to re-transmit, distribute or commercialise the material without obtaining prior

written approval from the Commonwealth. Further details can be found at

Public Summary

Page 2 of

Produced at 11.01.2021 at 11:53:04 AEDT

This is not an ARTG Certificate document.

The onus is on the reader to verify the current accuracy of the information on the document subsequent to the date shown.

Visit for contact information

Similar products

Search alerts related to this product

Share this information